An Advanced Review on Resealed Erythrocytes
DOI:
https://doi.org/10.22270/ajprd.v7i6.606Keywords:
resealed erythrocytes technology, Erythrocyte carriers, Nano devices, drug loading.Abstract
Now a days there are numerous applications have been proposed for the use of resealed erythrocytes as carrier for drugs, enzyme replacement therapy etc. Until other carrier systems come of age, resealed erythrocytes technology will remain an active field for the further research. The use of resealed erythrocytes shows potential for a safe and effective delivery of various bioactive molecules for effective targeting. In coming future, erythrocyte based drug delivery system with their capability to afford controlled and site specific drug delivery have been developed for disease management. Erythrocyte carriers are “Nano devices in the field of Nanotechnology”. A large amount of valuable work is needed so as to utilize the potentials of erythrocytes in passive as well as active targeting of drugs in diseases like cancer. At present erythrocytes are most effective carriers in novel drug delivery systems considering their tremendous potential. Hence the present article is reviewed about method of drug loading, evaluation and applications of RSE.
Downloads
References
2. Jangde R. An Overview of resealed erythrocyte for cancer therapy. Asian Journal of Research in Pharmaceutical Science. 2011; 1(4):83-92.
3. Kolhe SR, Sontakke S. Resealed Erythrocytes: An Advanced Review. International Journal of Pharmaceutical Sciences and Research. 2012; 13(12):4583.
4. Sharma M, Jain S. Resealed Erythrocytes-As a Carrier. PharmaTutor. 2014 May 1;2(5):10-8.
5. Behl T, Kaur I, Misri RW, Goel H. Resealed Erythrocytes as A Potential Drug Carrier: A Review. PharmaTutor. 2014 Aug 1; 2(8):73-8.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).